These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Prognostic value of clinical staging of prostatic cancer with regard to the degree of histopathological malignancy]. Szymanowski J; Wasilewski A Pol Tyg Lek; 1982 Jul; 37(24-25):709-12. PubMed ID: 7177967 [No Abstract] [Full Text] [Related]
11. [Morphology of prostate carcinoma in biopsies and total prostatectomies. Relevance of biopsy findings]. Kastendieck H Pathologe; 1980 Nov; 2(1):31-43. PubMed ID: 7465545 [No Abstract] [Full Text] [Related]
12. [Functional results and oncologic control after anatomic radical prostatectomy]. Rohner S; Graber P Ann Urol (Paris); 1994; 28(4):190-5. PubMed ID: 7979208 [TBL] [Abstract][Full Text] [Related]
13. [Recent data about prostatic carcinoma (author's transl)]. Coune A Rev Med Brux; 1980 May; 1(5):311-4. PubMed ID: 7466030 [No Abstract] [Full Text] [Related]
17. A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour. Lipponen P; Vesalainen S; Kasurinen J; Ala-Opas M; Syrjänen K Anticancer Res; 1996; 16(4A):2095-100. PubMed ID: 8712749 [TBL] [Abstract][Full Text] [Related]
18. Staging of M0 prostatic adenocarcinoma: how aggressive should one be? Olsson CA Prog Clin Biol Res; 1984; 153():455-67. PubMed ID: 6473408 [No Abstract] [Full Text] [Related]
19. Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients. Song SY; Kim SR; Ahn G; Choi HY Prostate Cancer Prostatic Dis; 2003; 6(2):143-7. PubMed ID: 12806373 [TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]